Mark Haden

  • Director of Clinical Research - Psygen
  • Adjunct professor at the University of British Columbia School of Public and Population Health.
  • Was Executive Director of MAPS Canada (Multidisciplinary Association for Psychedelic Studies) for 10 years.
  • Has published on the issue of drug control policy and psychedelics in the following Journals:
  • Canadian Journal of Public Health,
  • International Journal of Drug Policy,
  • Encyclopaedia of Public Health
  • Harm Reduction Journal
  • Open Medicine
  • Journal of Psychoactive Drugs
  • Journal of Studies on Alcohol and Drugs
  • Obtained an MSW from UBC
  • Worked for the Addiction Services for 28 years in counselling and supervisory roles.
  • Has provided public education on drugs and drug policy for over 30 years.
  • Works with the Health Officers Council of British Columbia on their position papers on the issue of a regulated market for all currently illegal drugs.
  • Has presented in conferences and training events in many countries
  • Awarded the Queen’s Diamond Jubilee Medal for drug policy reform work in 2013.


Clinical Use of Psychedelics in Psychotherapy